Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 9/11/2018
SIETES contiene 92577 citas

 
 
 1 a 10 de 10 
Presentar resultados
Seleccionar todas
1. Cita con resumen
Naci H, Carter AW, Mossialos E. Why the drug development pipeline is not delivering better medicines. BMJ 2015;351:h5542. [Ref.ID 99639]
2. Cita con resumen
Sorenson C, Naci H, Cylus J, Mossialos E. Evidence of comparative efficacy should have a formal role in European drug approvals. BMJ 2011;343:514-7. [Ref.ID 91460]
3.Tiene citas relacionadas Cita con resumen
Morel C, Mossialos E. Stocking the antibiotic pipeline. BMJ 2010;340:1115-8. [Ref.ID 88555]
4.
Miladovsky P, Mossialos E, McKee M. Improving access to research data in Europe. BMJ 2008;336:287-8. [Ref.ID 82150]
5.
Mrazek MF, Mossialos E. Increasing demand while decreasing costs of generic medicines. Lancet 2000;356:1784-5. [Ref.ID 54053]
6. Cita con resumen
Mossialos E, McKee M. A new European health strategy. BMJ 2000;321:6. [Ref.ID 51689]
7.
Kanavos P, Mossialos E. Outstanding regulatory aspects in the European pharmaceutical market. Pharmacoeconomics 1999;15:519-33. [Ref.ID 44979]
8.
McKee M, Mossialos E. The impact of managed care on clinical research. Pharmacoeconomics 1998;14:19-25. [Ref.ID 39125]
9. Cita con resumen
López Bastida J, Mossialos E. Spanish drug policy at the crossroads. Lancet 1997;350:679-80. [Ref.ID 35335]
10.
Mossialos E, Kanavos P, Abel-Smith B. Will managed care work in Europe?. Pharmacoeconomics 1997;11:297-305. [Ref.ID 31411]
Seleccionar todas
 
 1 a 10 de 10